Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciara Conduit

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Nature Reviews. Urology|March 7, 2023
Treatment de-escalation for stage II seminomaGeorgina E Wood, Florence Chamberlain, Ben Tran, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 8, 2022
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-upCiara Conduit, Thuan Tzen Koh, Michael S Hofman, et al.
Therapeutic Advances in Medical Oncology|March 16, 2026
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapiesCiara Conduit, Bruno Valentin Sinn, Catherine Mitchell, et al.
Basic and Clinical Andrology|September 2, 2024
Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysisGrace Y Kim, Ciara Conduit, Sophie O'Haire, et al.
BJU International|July 24, 2024
Pseudoephedrine for ejaculatory dysfunction after retroperitoneal lymph node dissection in testicular cancerCiara Conduit, Jeremy Lewin, Wei Hong, et al.
BJU International|March 12, 2024
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancerDickon Hayne, Katherine Ong, Nicole Swarbrick, et al.
BJUI Compass|August 1, 2025
Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumoursNasreen Abdul Aziz, Kenrick Ng, Constantine Alifrangis, et al.
Future Oncology (London, England)|June 30, 2025
Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language reviewPaul E Dato, Jose De La Cerda, Andrew J Armstrong, et al.
European Urology Oncology|October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
JMIR Cancer|October 28, 2022
Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods StudyCiara Conduit, Christina Guo, Allan B Smith, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Nature Reviews. Urology|March 7, 2023
Treatment de-escalation for stage II seminomaGeorgina E Wood, Florence Chamberlain, Ben Tran, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 8, 2022
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-upCiara Conduit, Thuan Tzen Koh, Michael S Hofman, et al.
Therapeutic Advances in Medical Oncology|March 16, 2026
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapiesCiara Conduit, Bruno Valentin Sinn, Catherine Mitchell, et al.
Basic and Clinical Andrology|September 2, 2024
Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysisGrace Y Kim, Ciara Conduit, Sophie O'Haire, et al.
BJU International|July 24, 2024
Pseudoephedrine for ejaculatory dysfunction after retroperitoneal lymph node dissection in testicular cancerCiara Conduit, Jeremy Lewin, Wei Hong, et al.
BJU International|March 12, 2024
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancerDickon Hayne, Katherine Ong, Nicole Swarbrick, et al.
BJUI Compass|August 1, 2025
Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumoursNasreen Abdul Aziz, Kenrick Ng, Constantine Alifrangis, et al.
Future Oncology (London, England)|June 30, 2025
Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language reviewPaul E Dato, Jose De La Cerda, Andrew J Armstrong, et al.
European Urology Oncology|October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
JMIR Cancer|October 28, 2022
Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods StudyCiara Conduit, Christina Guo, Allan B Smith, et al.
Pageof 3